UiPath, Inc. stock holds bullish trend as RSI hits 71, but Mizuho sees $14

10 hours ago 16
UiPath, Inc. stock

UiPath, Inc. stock maintains a strong daily uptrend, but the hourly chart shows clear signs of post-earnings fatigue. The broader structure still points higher. However, the short-term pause deserves attention before assuming the rally continues uninterrupted.

PATH daily chart with EMA20, EMA50 and volumePATH — daily chart with candlesticks, EMA20/EMA50 and volume.

Key takeaways

  • PATH closed at 18.22 on Thursday, with a daily range of 17.90 to 18.83 and heavy volume of roughly 60.3 million shares.
  • The daily EMA stack is fully aligned bullish, with the 20-period at 16.59, the 50-period at 14.59, and the 200-period at 12.92.
  • Daily RSI14 sits at 71.04 in overbought territory, while hourly RSI14 has cooled sharply to 51.78.
  • FY2027 revenue guidance ranges from $1.789 billion to $1.794 billion, with non-GAAP operating income of approximately $445 million.
  • Near-term support for PATH lies at 17.98–17.80, while resistance extends from 18.73 to the upper Bollinger Band at 18.93.

Daily Trend: Bullish Structure for UiPath, Inc. Stock, But Stretched

The daily chart for UiPath, Inc. stock remains firmly bullish. Price sits well above all major moving averages in ascending order, confirming an established uptrend. On the daily timeframe, PATH closed at 18.22 after trading between 17.90 and 18.83. Volume reached roughly 60.3 million shares, consistent with a stock reacting to fresh earnings news.

The EMA stack tells a clear story. The 20-period EMA sits at 16.59, the 50-period at 14.59, and the 200-period at 12.92. Price above all three in ascending order is a textbook bullish confirmation. The system’s regime tag agrees, labeling the daily setup as bullish.

However, RSI14 on the daily chart is at 71.04, firmly in overbought territory. That does not invalidate the trend. But it raises the odds of a cooling-off period or sideways digestion before the next leg. MACD adds a similar nuance. The line sits at 1.32, above the signal at 1.27, keeping the histogram positive at 0.05. Momentum remains technically bullish. Yet the thin histogram shows the pace of the advance is decelerating rather than accelerating.

Meanwhile, the Bollinger Bands show price hugging the upper band. The mid-line sits at 16.67 and the upper band at 18.93. That is consistent with a strong trending move. However, proximity to the upper band increases the risk of a short-term mean-reversion pullback. The ATR14 of 0.76 confirms daily ranges have expanded meaningfully, typical after an earnings catalyst. Pivot levels place the pivot point at 18.32, resistance R1 at 18.73, and support S1 at 17.80. Notably, Thursday’s close landed just below the pivot. This is a small but real sign of hesitation right at the point of control.

Hourly Picture: PATH Consolidation, Not Confirmation

The hourly chart shows PATH in a neutral consolidation. Momentum has stalled after the initial earnings move, contrasting with the daily bullish structure. On the 1H chart, price closed at 18.25, essentially flat versus the 18.25 open of that candle. The EMA20 sits right at 18.25, with the EMA50 at 17.89 and the EMA200 at 15.86. Structurally, the uptrend is intact since price remains above both the 50 and 200-period averages. At the same time, sitting exactly on the EMA20 shows the advance has lost its short-term thrust.

RSI14 on the hourly has dropped to 51.78, a sharp cooldown from the daily’s overbought 71.04. This marks a meaningful divergence between timeframes. MACD on the 1H is essentially flat. The line and signal are both at 0.10, and the histogram sits at zero. Momentum has neither expanded nor contracted. It has simply paused.

Price closed near the Bollinger Bands mid-line at 18.18, between the lower band at 17.72 and the upper band at 18.65. This reinforces consolidation rather than continuation. The hourly regime is explicitly tagged neutral, in direct contrast with the daily’s bullish label. In other words, the broader uptrend for UiPath, Inc. stock has not broken down. But short-term buyers have stepped back after the initial earnings reaction. Pivot levels here sit at 18.16, 18.42 for R1, and 17.98 for S1. This tight range will likely define the next few sessions.

15-Minute Execution Context

On the 15-minute timeframe, PATH shows a minor bearish tilt within the broader hourly pause. Price closed at 18.25 after opening at 17.98, with a session range between 17.96 and 18.27. Here, price trades below its EMA20 at 18.34 and EMA50 at 18.30, though it remains above the EMA200 at 17.86.

RSI14 at 46.17 is soft but not alarming. MACD, however, is negative on this timeframe. The line sits at -0.02, below the signal at 0.03, producing a histogram of -0.06. This points to short-term selling pressure building intraday. Bollinger Bands show price below the 18.42 mid-line and closer to the lower band at 18.13 than the upper band at 18.71. The 15-minute pivot sits at 18.16, with S1 at 18.05 close by. Holding above this level keeps the pullback shallow. A break lower opens room toward the hourly S1 near 17.98.

What the News Flow Adds for UiPath, Inc. Stock

Earnings results and analyst reactions paint a mixed but fundamentally solid picture. UiPath’s Q2 FY2027 earnings call showed ARR growth of 12%, improving margins, and traction in AI-heavy deals. Guidance points to revenue between $1.789 billion and $1.794 billion, with non-GAAP operating income of about $445 million. The company is also navigating a finance leadership transition.

Analyst reaction was mixed in tone despite the solid quarter framing. Wells Fargo raised its price target on UiPath following the results. Mizuho also raised its target, to $14, describing the results as strong. Notably, that target sits below the current trading price near 18.22. This discrepancy is worth flagging for anyone tracking PATH analyst rating updates. At the same time, a separate headline asked why UiPath stock was sliding on the day, amid a broader session where markets awaited the non-farm payrolls report. Overall, the news flow suggests genuine business momentum, but also some skepticism about how much further the current PATH stock price can extend near-term.

Bullish Scenario for PATH

The bullish case depends on the daily trend reasserting itself once the hourly consolidation resolves. If PATH can reclaim and hold above the daily pivot at 18.32, with the 1H chart pushing back over its EMA20 at 18.25, the path toward daily R1 at 18.73 and the upper Bollinger Band near 18.93 stays open. Confirmation would come from the 1H RSI moving back above 55–60 and the 15-minute MACD flipping positive again. Fundamentally, continued ARR growth and expanding AI-driven deal activity would support renewed buying interest. A further round of raised price targets could also help sentiment.

Bearish Scenario for PATH Stock

On the other hand, the bearish risk centers on the overbought daily RSI finally triggering a deeper pullback. A break below the 1H support at 17.98, followed by a daily close under S1 at 17.80, would invalidate the near-term bullish setup. This would point toward a retest of the Bollinger mid-line near 16.67, or potentially the daily EMA50 at 14.59. The negative 15-minute MACD histogram is an early warning sign in this direction. Mizuho’s $14 target, sitting well below current levels, underscores that not every analyst view supports further upside from here. The finance leadership transition adds another layer of uncertainty that could weigh on sentiment if execution questions arise.

Closing Take

In summary, UiPath, Inc. stock is caught between a strong daily uptrend and a tired, consolidating hourly structure. Therefore, positioning around current levels calls for caution rather than conviction in either direction. Volatility, reflected in the elevated daily ATR of 0.76, is likely to stay high as the market digests both the earnings details and the split analyst reaction. Until the hourly chart either reclaims its EMA20 with fresh momentum or breaks down through the 17.98–17.80 support zone, the near-term outlook for PATH stays genuinely uncertain. The broader daily trend, however, remains technically bullish.

FAQ

What is the current trend for UiPath, Inc. stock?

The daily trend for UiPath, Inc. stock is firmly bullish. Price closed at 18.22, well above the aligned EMA stack with the 20-period at 16.59, the 50-period at 14.59, and the 200-period at 12.92. The system’s regime tag confirms a bullish setup. However, the hourly chart shows neutral consolidation following this week’s earnings report.

Is PATH stock overbought after earnings?

On the daily chart, yes. Daily RSI14 sits at 71.04, firmly in overbought territory. However, the hourly RSI14 has already cooled sharply to 51.78, signaling that short-term momentum has stalled. The overbought daily reading does not invalidate the uptrend, but it raises the odds of a near-term pause or pullback.

What are the key support and resistance levels for PATH?

Key support for PATH lies at 17.98 (hourly S1) and 17.80 (daily S1). A breakdown below this zone would open the door toward the Bollinger mid-line near 16.67. On the upside, resistance sits at 18.32 (daily pivot), 18.73 (daily R1), and the upper Bollinger Band at 18.93.

What did analysts say about UiPath’s latest earnings?

Analyst reaction was mixed. Wells Fargo raised its price target on UiPath following the results. Mizuho also raised its target, to $14, describing the quarter as strong. However, Mizuho’s target remains below the current trading price near 18.22, which highlights ongoing skepticism about near-term upside.


Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Read Entire Article